The "spectacular" success of mRNA (messenger ribonucleic acid) vaccine technology against SARS-CoV-2 provides "just a glimpse of their full potential", according to the authors of a Perspective published by the Medical Journal ...
Jul 5, 2022
0
4
Back in spring 2009, the H1N1 influenza virus crossed the U.S. border and raised concerns that it might cause a full-scale epidemic in the fall. The Food and Drug Administration worked with other Health and Human Services ...
Jul 5, 2011
1
0
The unprecedented scaling-up of vaccine manufacturing to counter COVID-19 has sparked dangerous shortages in the supply chain, global players acknowledged Tuesday after brainstorming how to speed up production of the jabs.
Mar 10, 2021
0
2
In an industrial neighborhood on the outskirts of Bangladesh's largest city lies a factory with gleaming new equipment imported from Germany, its immaculate hallways lined with hermetically sealed rooms. It is operating at ...
Mar 1, 2021
0
9
Administering both the pneumococcal and the herpes zoster vaccines to patients during the same visit is beneficial and does not appear to compromise the protective effect of the zoster vaccine, according to a Kaiser Permanente ...
May 12, 2011
0
0
AstraZeneca on Wednesday denied reports it was stockpiling coronavirus vaccines in the EU to export to Britain, after Italian inspectors found 29 million doses in a manufacturing plant.
Mar 24, 2021
0
5
The global epidemic innovations fund said Tuesday it was working with a vaccine manufacturer to create a patch using mRNA technology, which would be easier to use against COVID.
Jan 17, 2023
0
5
The U.S. Food and Drug Administration on Wednesday gave the green light to updated COVID-19 booster shots from both Pfizer and Moderna that target omicron variants, paving the way for the shots to get into American arms within ...
Aug 31, 2022
0
9
The death toll from a flu outbreak gripping the United States has reached epidemic levels and it will be at least several weeks before the outbreak abates, health officials said Friday.
Jan 12, 2013
1
0
Globally affordable COVID-19 vaccines will not be accessible until governments stop allowing vaccine companies to keep their manufacturing costs secret, according to a new paper published by the Journal of the Royal Society ...
Nov 4, 2021
0
1
